Plasma biomarker and stroke

Cerebrovascular Diseases

Volumn 32, Issue 4, 2011, Pages 406-

  Meng, Ran ^a,b   Ji, Xunming ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; HOSPITAL ADMISSION; HUMAN; LETTER; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80053545169     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000331927     Document Type: Letter

References (4)

1. Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, Welsh P, Green A, Andrews M, Graham C, Sandercock P: Blood biomarkers for the diagnosis of acute cerebrovascular diseases: A prospective cohort study. Cerebrovasc Dis 2011; 32: 141-147.
2. Meng R, Li ZY, Ji X, Ding Y, Meng S, Wang X: Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke. Clin Neurol Neurosurg 2011; 113: 380-386.
3. Hanson E, Jood K, Karlsson S, Nilsson S, Blomstrand C, Jern C: Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke. J Thromb Haemost 2011; 9: 275-281.
4. Meng R, Ji X, Li B, Zhou J, Li W, Ding Y: Dynamical levels of plasma F(1+2) and D-dimer in patients with acute cerebral infarction during intravenous urokinase thrombolysis. Neurol Res 2009; 31: 367-370.